Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array

Treatment for patients with newly diagnosed multiple myeloma in 2015

(2015) María-Victoria Mateos et al.   BLOOD REVIEWS

Bortezomib-induced peripheral neurotoxicity: an update

(2014) Andreas A. Argyriou et al.   ARCHIVES OF TOXICOLOGY

A Partial Least Squares Algorithm for Microarray Data Analysis Using the VIP Statistic for Gene Selection and Binary Classification

(2014) Francisco Burguillo et al.   Current Bioinformatics

Bortezomib-induced peripheral neuropathy is related to altered levels of brain-derived neurotrophic factor in the peripheral blood of patients with multiple myeloma

(2013) David Azoulay et al.   BRITISH JOURNAL OF HAEMATOLOGY

WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013

(2013) Jing Wang et al.   NUCLEIC ACIDS RESEARCH

Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients

(2011) S. L. Corthals et al.   HAEMATOLOGICA

DNA microarray SNP associations with clinical efficacy and side effects of domperidone treatment for gastroparesis

(2011) Dairong Wang et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma

(2011) David C. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic variation associated with bortezomib-induced peripheral neuropathy

(2011) Reyna Favis et al.   Pharmacogenetics and Genomics

Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

(2010) Meletios A. Dimopoulos et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Peripheral neuropathy and new treatments for multiple myeloma: background and practical recommendations

(2010) B. Mohty et al.   HAEMATOLOGICA

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial

(2010) María-Victoria Mateos et al.   LANCET ONCOLOGY

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

(2010) Annemiek Broyl et al.   LANCET ONCOLOGY

Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues

(2010) Michel Delforge et al.   LANCET ONCOLOGY

Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy

(2009) Vinay Chaudhry et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM